Human Pathology
Volume 37, Issue 1 , Pages 92-100 , January 2006

Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death

  • Lian-hua Kim, MMedSc, PhD

      Affiliations

    • Department of Pathology, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia
    • ,
  • Suat-cheng Peh, MBBS, MPath, FRCPath, FRCPA, PhD

      Affiliations

    • Department of Pathology, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia
    • Corresponding Author InformationCorresponding author.
    • ,
  • Sibrand Poppema, MD, PhD, FRCPC

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands

Received 29 March 2005 ,Accepted 23 September 2005.

References 

  1. Liggett WHJ, Sidransky D. Role of P16 tumour suppressor gene in cancer. J Clin Oncol. 1998;16:1197–1206
  2. Hangaishi A, Ogawa S, Imamura N, et al. Inactivation of multiple tumour-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood. 1996;87:4949–4958
  3. Cairns P, Polascik TJ, Eby Y, et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet. 1995;11:210–212
  4. Herman JG, Civin CI, Issa JPJ, Collector MI, Sharkis SJ, Baylin SB. Distinct patterns of inactivation of p15INK4B and p16INK4A characterise the major types of hematological malignancies. Cancer Res. 1997;57:837–841
  5. Adams PD. Regulation of the retinoblastoma tumour suppressor protein by cyclin/CDKs. Biochim Biophys. 2001;1471:M123–M133
  6. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323–330
  7. Baur AS, Shaw P, Burri N, Delacretaz F, Bosman FT, Chaubert P. Frequent methylation silencing of p15INK4b (MTS2) and p16INK4a (MTS1) in B-cell and T-cell lymphomas. Blood. 1999;94:1773–1781
  8. Ogawa S, Hangaishi A, Miyawaki S, et al. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood. 1995;86:1548–1556
  9. Guenova M, Rassidakis GZ, Gorgoulis VG, et al. P16INK4A is regularly expressed in Hodgkin's disease: comparison with retinoblastoma, p53 and MDM2 protein status, and the presence of Epstein-Barr virus. Mod Pathol. 1999;12:1062–1071
  10. Geradts J, Wilentz RE, Roberts H. Immunohistochemical detection of the alternate INK4A-encoded tumour suppressor protein p14ARF in archival human cancers and cell lines using commercial antibodies: correlation with p16INK4A expression. Mod Pathol. 2001;14:1162–1168
  11. Elenitoba-Johnson KSJ, Gascoyne RD, Lim MS, Chhanabai M, Jaffer ES, Raffeld M. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle centre lymphoma. Blood. 1998;91:4677–4685
  12. Harris NL. Hodgkin's disease: classification and differential diagnosis. Mod Pathol. 1999;12:159–176
  13. Gerdes J, Van Baarlen J, Pileri S, Schwarting R, Van Unnik JAM, Stein H. Tumour cell growth fraction in Hodgkin's disease. Am J Pathol. 1987;128:390–393
  14. Montisinos-Rongen M, Roers A, Kuppers R, Rajewsky K, Hansmann ML. Mutation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg cells in Hodgkin's disease. Blood. 1999;94:1755–1760
  15. Kanavaros P, Stefanaki K, Vlachonikolis J, et al. Expression of p53, p21/waf1, Bcl-2, bax, Rb, Ki67 proteins in Hodgkin's lymphomas. Histol Histopathol. 2000;15:445–453
  16. Schlaifer D, Krajewski S, Rigal-Huhuet F, et al. Bcl-x gene expression in Hodgkin's disease. Leuk Lymphoma. 1996;23:143–146
  17. Brousset P, Benharroch D, Krajewski S, et al. Frequent expression of the cell death–inducing gene Bax in Reed-Sternberg cells of Hodgkin's disease. Blood. 1996;87:2470–2475
  18. Garcia JF, Villuendas R, Algara P, et al. Loss of p16 protein expression associated with methylation of the p16INK4A gene is a frequent finding in Hodgkin's disease. Lab Invest. 1999;79:1453–1459
  19. Ohtani N, Brennan P, Gaubatz S, et al. Epstein-Barr virus LMP1 blocks p16INK4A-RB pathway by promoting nuclear export of E2F4/5. J Cell Biol. 2003;162:173–183
  20. Kim LH, Veera S, Peh SC, Poppema S. Expression of Bcl-2 family members and presence of EBV in cell growth and death in classical Hodgkin's lymphoma. Histopathology. 2004;44:257–267
  21. Garcia JF, Camacho FI, Morente M, et al. Hodgkin and Reed-Sternberg cells harbour alterations in the major tumour suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood. 2003;101:681–689
  22. Pinyol M, Hernandez L, Cazorla M, et al. Deletions and loss of expression of p16INK4A and p21WAF1 genes are associated with aggressive variants of mantle cell lymphoma. Blood. 1997;89:272–280
  23. Joos S, Menz CK, Wrobel G, et al. Classical Hodgkin's lymphoma is characterised by recurrent copy number gains of the short arm of chromosome 2. Blood. 2002;99:1381–1387
  24. Shaminie J, Peh S, Tan M. Improvement in the detection rate of t(14;18) translocation on paraffin-embedded tissue: a combination approach using PCR and FISH. Pathology. 2003;35:414–421
  25. Tai YC, Kim LH, Peh SC. Common ALK gene rearrangement in Asian CD30+ anaplastic large cell lymphoma: an immunohistochemical and fluorescence in situ hybridisation (FISH) study on paraffin-embedded tissue. Pathology. 2003;35:436–443
  26. Gupta RK, Lister TA, Bodmer JG. Proliferation of Reed-Sternberg cells and variant in Hodgkin's disease. Ann Oncol. 1994;5(Suppl 1):S117–S119
  27. Sanchez-Beato M, Martinez-Montero JC, Doussis-Anagnostopoulou TA, et al. Anomalous retinoblastoma protein expression in Sternberg-Reed cells in Hodgkin's disease: a comparative study with p53 and Ki67 expression. Br J Cancer. 1996;74:1056–1062
  28. Morente MM, Piris MA, Abraira V, et al. Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus latent membrane protein–1 expression. Blood. 1997;90:2429–2436
  29. Martinez JC, Oiris MA, Sanchez-Beato M, et al. Retinoblastoma (Rb) gene product expression in lymphomas. Correlation with Ki-67 growth fraction. J Pathol. 1993;169:405–412
  30. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature. 1994;351:453–456
  31. Maggio EM, Stekelenburg E, Van Den Berg A, Poppema S. TP53 gene mutations in Hodgkin's lymphoma are infrequent and not associated with absence of Epstein-Barr virus. Int J Cancer. 2001;94:60–66
  32. Bellamy COC. p53 and apoptosis. Br Med Bull. 1996;53:522–538
  33. Szekely L, Selivanova G, Magnusson KP, Klein G, Wiman KG. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci U S A. 1993;15:5455–5459
  34. Inman GJ, Farrell PJ. Epstein-Barr virus EBNA-LP and transcription regulation properties of pRB, p107 and p53 in transfection assays. J Gen Virol. 1995;76:2141–2149
  35. Yang X, He Z, Xin B, Cao L. LMP-1 of Epstein-Barr virus suppresses cellular senescence associated with the inhibition of p16INK4A expression. Oncogene. 2000;19:2000–2013

☆ This study was supported by the Malaysian Ministry of Science, Technology, and Innovation research grant: Top-Down Biotechnology 26-02-03-0586; and the Malaysia TORAY Science Foundation Research Fellowship awarded to L. H. Kim.

PII: S0046-8177(05)00535-6

doi: 10.1016/j.humpath.2005.09.028

Human Pathology
Volume 37, Issue 1 , Pages 92-100 , January 2006

Article Tools

* Image Usage & Resolution